Literature DB >> 10344735

Identification of the TCL1/MTCP1-like 1 (TML1) gene from the region next to the TCL1 locus.

J Sugimoto1, T Hatakeyama, M G Narducci, G Russo, M Isobe.   

Abstract

The region on chromosome 14q32.1 is frequently involved in chromosomal translocations and inversions with one of the T-cell receptor loci in human T-cell leukemias and lymphomas. The breakpoints of the different rearrangements segregate into two clusters: inversion on the centromeric side and simple balanced translocations on the telomeric side. If the target gene activated by these different types of chromosomal rearrangements is the same, the gene must reside between the two clusters of breakpoints in a region of approximately 160 kb. By screening of a placenta cDNA library using genomic probes derived from the vicinity of TCL1 locus, we have identified a gene coding for a 1.7-kb transcript that is expressed in leukemic cells carrying a t(14;14)(q11;q32) chromosome translocation. The cognate cDNA sequence reveals an open reading frame of 384 nucleotides encoding a Mr 15,000 protein with approximately 30% of homology with both p14TCL1 and p13MTCP1 oncoproteins. The genomic organization of the TML1 locus was characterized, with three exons located 15 kb from and tail-to-tail in relation to TCL1 locus. Because of its location and sequence similarity with TCL1 and MTCP1 oncoproteins, this gene, named TML1 (TCL1/MTCP1-like 1) is a candidate gene that is potentially involved in leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10344735

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Molecular characterization of a novel translocation t(5;14)(q21;q32) in a patient with congenital abnormalities.

Authors:  Shawkat Haider; Rie Matsumoto; Nobuyuki Kurosawa; Keiko Wakui; Yoshimitsu Fukushima; Masaharu Isobe
Journal:  J Hum Genet       Date:  2006-02-24       Impact factor: 3.172

2.  Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitro.

Authors:  Ke Lan; Masanao Murakami; Tathagata Choudhuri; Donald E Tsai; Stephen J Schuster; Mariusz A Wasik; Erle S Robertson
Journal:  J Clin Virol       Date:  2008-09-14       Impact factor: 3.168

Review 3.  Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.

Authors:  Philipp B Staber; Marco Herling; Mar Bellido; Eric D Jacobsen; Matthew S Davids; Tapan Mahendra Kadia; Andrei Shustov; Olivier Tournilhac; Emmanuel Bachy; Francesco Zaja; Kimmo Porkka; Gregor Hoermann; Ingrid Simonitsch-Klupp; Claudia Haferlach; Stefan Kubicek; Marius E Mayerhoefer; Georg Hopfinger; Ulrich Jaeger; Claire Dearden
Journal:  Blood       Date:  2019-07-10       Impact factor: 22.113

4.  The TCL1 function revisited focusing on metabolic requirements of stemness.

Authors:  Maria Teresa Fiorenza; Alessandro Rava
Journal:  Cell Cycle       Date:  2019-09-29       Impact factor: 4.534

5.  Reduced level of the BCL11B protein is associated with adult T-cell leukemia/lymphoma.

Authors:  Nobuyuki Kurosawa; Rika Fujimoto; Tatsuhiko Ozawa; Takahiro Itoyama; Naoki Sadamori; Masaharu Isobe
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

6.  TCL1 participates in early embryonic development and is overexpressed in human seminomas.

Authors:  Maria Grazia Narducci; Maria Teresa Fiorenza; Sang-Moo Kang; Arturo Bevilacqua; Monica Di Giacomo; Daniele Remotti; Maria Cristina Picchio; Vincenzo Fidanza; Max D Cooper; Carlo Maria Croce; Franco Mangia; Giandomenico Russo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.